China's CanSino cuts ties with Brazil firm, halting vaccine licensing. “Brazilian health regulator Anvisa has canceled a request for emergency use authorization for the COVID-19 vaccine developed by China's CanSino Biologics Inc after the laboratory cut ties with its Brazilian representative. The move follows a wave of scrutiny in Brazil of vaccine contracts negotiated by intermediaries, a common local practice.”
Reuters: https://news.trust.org/item/20210629130003-jxn8t/
India’s Covid-19 vaccine is at the center of a corruption scandal in Brazil. “India’s homegrown Covid-19 vaccine is at the epicentre of a controversy again. Brazil’s health minister Marcelo Queiroga announced…the country would suspend a $324 million contract to buy 20 million doses of Bharat Biotech’s Covaxin. The announcement comes amid a probe into allegations of irregularities in the procurement of the vaccine that are entangling president Jair Bolsonaro,”
Niharika Sharma/Quartz India: https://qz.com/india/2027345/brazil-suspends-deal-with-indias-bharat-biotech-for-covaxin/
Corruption issues force PRRD to halt reclamation projects. “President Rodrigo Duterte revealed that he thumbed down the proposals of private companies to conduct massive land reclamation activities in Manila Bay because of corruption issues.”
Ruth Abbey Gita-Carlos/Philippines News Agency: https://www.pna.gov.ph/articles/1145043
No comments:
Post a Comment
Share your comments here:
Note: Only a member of this blog may post a comment.